Medicament Surgipharm LLP

Lcikinase 1,500,000 IU Injection is a thrombolytic agent used to treat acute myocardial infarction (heart attack), pulmonary embolism, and other conditions caused by blood clots. It contains Streptokinase 1,500,000 IU, which works by converting plasminogen to plasmin, helping dissolve clots and restore normal blood flow.

This injection is commonly prescribed in emergency situations for patients with acute heart attacks or severe thromboembolic events. Lcikinase Injection is administered intravenously under strict medical supervision to ensure safety and effective clot dissolution.

Key Features & Benefits:

• Contains Streptokinase 1,500,000 IU, a potent thrombolytic agent.

• Rapidly dissolves blood clots to restore normal circulation.

• Administered IV by trained healthcare professionals in emergency settings.

• Helps reduce complications from myocardial infarction and pulmonary embolism.

• Ideal for hospital and critical care use.